Analytical Procedure Lifecycle Management / Revisions to ICH Q2 & the proposed Q14 This conference is part of PharmaLab 2019

Analytical Procedure Lifecycle Management / Revisions to ICH Q2 & the proposed Q14 This conference is part of PharmaLab 2019

Düsseldorf/Neuss, Germany

Course No 200032


Costs

This training/webinar cannot be booked. To find alternative dates for this training/webinar or similar events please see the events list by topic.

For many training courses and webinars, there are also recordings you can order and watch any time. You can find these recordings in a list sorted by topic.

Or simply send us your inquiry by using the following contact form.

* also payable by credit card American Express Visa Mastercard

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Programme

Programme - 12 November 2019
Congress Keynote 12.11.2019: New ICH Q14 and ICH Q2 Revision – an industry view (Key Note Presentation at the Plenum)

New ICH Q14 and ICH Q2 Revision – an industry view (Keynote Presentation at the Plenum)
Dr Joachim Ermer, Sanofi-Aventis Deutschland Head of QC Lifecycle Management Frankfurt Chemistry

Introduction to ECA AQCG
Dr Christopher Burgess, Chairman of the ECA AQCG Board

Overview of USP, ICH revisions & APLM Guideline; Prerequisites and approaches
Dr Christopher Burgess, Chairman of the ECA AQCG Board

Introduction to ATP & TMU
Phil Borman, GSK

Data integrity over the Analytical Procedure Lifecycle
Bob McDowall, R.D. McDowall Limited

Stage 1: Procedure Design & Development
Margarita Sabater, Dako Denmark, an Agilent Technologies Company

Stage 1 in Practice
Phil Borman, GSK

Analytical Control Strategy Workshop
Dr Gerd Jilge, Boehringer Ingelheim
Margarita Sabater, Dako Denmark, an Agilent Technologies Company
Programme - 13 November 2019
Congress Keynote 13.11.2019: Laboratory Services - from Outsourcing to a strategic partnership (Key Note Presentation at the Plenum)

Laboratory Services - from Outsourcing to a strategic partnership (Key Note Presentation at the Plenum)
Dr Jürgen Balles, Dr Thomas Meindl and Ingo Grimm, Labor LS

Stage 2: Procedure Performance Qualification: Problems and issues?
Dr Gerd Jilge, Boehringer Ingelheim

Approaches to the transfer of Analytical Procedures
Ulla Bondegaard, Novo Nordisk

Stage 3: Procedure Performance Verification
Silviya Dimitrova, Teva

Experiences in the ongoing verification of Analytical Procedures
Ulla Bondegaard, Novo Nordisk

"What happens with Legacy Products?" Workshop
Silviya Dimitrova, Teva
Dr Christopher Burgess, Burgess Analytical Consultancy

Go back

GMP Conferences by Topics